Product Description
Unlock unparalleled treatment for hormone receptor-positive, metastatic breast cancer in postmenopausal women with FULVETHER 250MG! This outstanding prescription anticancer solution contains 250 mg of fulvestrant per 5 ml glass vial, specially formulated for intramuscular injection. With its neutral pH, odorless, and clear to yellowish viscous solution, FULVETHER 250MG ensures ultimate safety and efficacy. Ready-to-use, single-dose vials guarantee convenience and reliability. Limited stock availableGet It Now to secure access to this exceptional, long-acting estrogen receptor antagonist, exclusively supplied by leading distributors and exporters from India!
Competitive Advantages and Applications of FULVETHER 250MG
FULVETHER 250MG offers an exceptional therapeutic solution in oncology, providing long-acting estrogen receptor antagonism specifically for advanced breast cancer in postmenopausal women. Its ready-to-use, single-dose vial streamlines treatment, minimizing preparation time and enhancing safety. Designed for intramuscular administration, this product is suited for hospital oncology units, specialty clinics, and cancer treatment centers. By targeting hormone receptor pathways, FULVETHER delivers competitive efficacy in metastatic breast cancer therapy.
Sample Policy & Export Market Reach for FULVETHER 250MG
We offer a straightforward sample policy for FULVETHER 250MG, allowing qualified healthcare institutions to request evaluation samples for shipment. Main export markets include Asia, Africa, the Middle East, and select European nations. Each shipment is carefully packaged to ensure goods transport under optimal storage conditionsbelow 30C and protected from light. Samples are available upon formal request, in accordance with local regulations and prescription requirements.
FAQs of FULVETHER 250MG:
Q: How is FULVETHER 250MG administered to patients?
A: FULVETHER 250MG is administered by intramuscular injection, typically in a clinical setting under the supervision of a healthcare professional.
Q: What are the main indications for using FULVETHER 250MG?
A: FULVETHER 250MG is indicated for the treatment of hormone receptor-positive, metastatic breast cancer in postmenopausal women.
Q: When should FULVETHER 250MG not be used?
A: FULVETHER 250MG should not be used in individuals with known hypersensitivity to fulvestrant or its excipients, during pregnancy, or while breastfeeding.
Q: What are the storage requirements for FULVETHER 250MG?
A: Store FULVETHER 250MG below 30C, protect it from light, and do not freeze to maintain product integrity.
Q: Where can FULVETHER 250MG be sourced and who can request samples?
A: FULVETHER 250MG is available from authorized distributors, exporters, and wholesalers in India. Healthcare professionals and institutions may request samples in accordance with regulatory guidelines.
Q: What benefits does FULVETHER 250MG offer compared to other treatments?
A: FULVETHER 250MG provides long-acting estrogen receptor antagonism, convenient single-dose vials, and a formulation suitable for effective breast cancer management.